| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 09/03/2009 | WO2009053733A3 Novel crystalline forms |
| 09/03/2009 | WO2009043466A3 Therapeutic use of the peptide gluten exorphin a5 |
| 09/03/2009 | WO2009043455A3 Therapeutic uses of angiogenin 108-122 and gluten exorphin a5 |
| 09/03/2009 | US20090221821 Adenosine receptor antagonists and methods of making and using the same |
| 09/03/2009 | US20090221689 Macrocyclic Modulators of the Ghrelin Receptor |
| 09/03/2009 | US20090221686 Modulation of the Transcription of Pro-Inflammatory Gene Products |
| 09/03/2009 | US20090221657 Compounds, Compositions Containing Them, Preparation Thereof and Uses Thereof I |
| 09/03/2009 | US20090221543 New corticosteroids |
| 09/03/2009 | US20090221487 Polyethlene glycol modifications of thymosin alpha-1 |
| 09/03/2009 | US20090221007 Diagnosis, prevention and treatment of crohn's disease using the ompc antigen |
| 09/03/2009 | US20090221006 Diagnosis, prevention and treatment of crohn's disease using the ompc antigen |
| 09/03/2009 | US20090220621 Pharmaceutical compositions of a non-enteric coated proton pump inhibitor with a carbonate salt and bicarbonate salt combination |
| 09/03/2009 | US20090220601 Autologous Oral Grafts |
| 09/03/2009 | US20090220586 Proteomimetic compounds as inhibitors of the interaction of nuclear receptor with coactivator peptides |
| 09/03/2009 | US20090220452 Method Of Producing A Modified (POLY) Peptide |
| 09/03/2009 | CA2716788A1 Substituted xanthine derivatives |
| 09/03/2009 | CA2716578A1 Methods for treating bowel diseases |
| 09/03/2009 | CA2716400A1 Method for increasing the activity of the immune system of a mammal at risk of inflammatory diseases |
| 09/03/2009 | CA2709863A1 Azetidine derivatives, their preparation and their application in therapy |
| 09/02/2009 | EP2096120A2 Use of secreted protein products for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome |
| 09/02/2009 | EP2096117A1 Process for producing erythromycin derivative |
| 09/02/2009 | EP2095817A1 Therapeutic compositions and methods |
| 09/02/2009 | EP2094720A1 Selective inhibitors of neurotensin degrading enzymes |
| 09/02/2009 | EP2094640A1 Alpha-substituted omega-3 lipids that are activators or modulators of the peroxisome proliferators-activated receptor (ppar). |
| 09/02/2009 | EP2094289A1 Conjoint therapy for treating fibrotic diseases |
| 09/02/2009 | EP1937672B1 N-[(4,5-diphenylpyrimidin-2-yl)methyl]amine derivatives, the preparation thereof and their therapeutic use |
| 09/02/2009 | EP1807422B1 5-ht4 receptor agonist compounds |
| 09/02/2009 | EP1641763B1 4-cyanopyrazole-3-carboxamide derivatives preparation and therapeutic application thereof |
| 09/02/2009 | EP1496890B1 Substituted beta-aminoalcohols used as medicaments |
| 09/02/2009 | EP1478233A4 Method for administering glp-1 molecules |
| 09/02/2009 | EP1470137B1 Edg receptor agonists |
| 09/02/2009 | EP1458392B1 Acridones as inhibitors of impdh enzyme |
| 09/02/2009 | EP1374863B1 Amino acid compositions for ameliorating liver failure |
| 09/02/2009 | EP1282617B1 Hydantoin derivatives with affinity for somatostatin receptors |
| 09/02/2009 | CN101519651A Shigella flexneri phage strain and application thereof |
| 09/02/2009 | CN101519418A Preparation method of hydrate of deoxycholic acid and magnesium salt |
| 09/02/2009 | CN101518646A Lipase-containing composition |
| 09/02/2009 | CN101518642A Oral liquid preparations |
| 09/02/2009 | CN101518641A Traditional Chinese preparation used for preventing and treating functional constipation |
| 09/02/2009 | CN101518637A Drug for treating female uterine prolapse and anal prolapse and preparation method thereof |
| 09/02/2009 | CN101518632A Traditional Chinese medical tablet |
| 09/02/2009 | CN101518619A Compound brain activation and comfort capsule and quality control method thereof |
| 09/02/2009 | CN101518616A Quality control method for Kouyangqing granules and application thereof |
| 09/02/2009 | CN101518609A Oral traditional Chinese medicine preparation for treating constipation |
| 09/02/2009 | CN101518591A Traditional Chinese medicine for treating diabetic constipation |
| 09/02/2009 | CN101518590A Preparation method of prepared radix rehmannia steamed and dried for nine times |
| 09/02/2009 | CN101518580A Pharmaceutical composition for clearing heat and releasing toxin as well as preparation method and application thereof |
| 09/02/2009 | CN101518568A Nanometer composite ant liver-nourishing anti-ageing energy-cumulative medicine |
| 09/02/2009 | CN101518566A Non-oral preparation of guava leaf total flavonoid aglycone, preparation method and application thereof |
| 09/02/2009 | CN101518553A Oral medicinal preparation of ginkgo leaf total flavonoid aglycone, preparation method and an application thereof |
| 09/02/2009 | CN101518548A Dietotherapy medicament for treating gastric ulcer and duodenal ulcer and preparation method thereof |
| 09/02/2009 | CN101518539A Drug combination |
| 09/02/2009 | CN101518527A Use of scutellarin in preventing or treating hepatofibrosis and method for preparing micropill thereof |
| 09/02/2009 | CN101518526A Drug combination |
| 09/02/2009 | CN101518509A Oral drug combination containing salvianolic acid A |
| 09/02/2009 | CN101518501A Dental resin composition utilizing reinforcing mechanism with mixed nanometer |
| 09/02/2009 | CN101518499A Light-cured composite resin for oral cavity by using single crystal diamond as filler and preparation method thereof |
| 09/02/2009 | CN101518353A Alcohol-detoxication inflammation-relieving liver-protection beverage and preparation method thereof |
| 09/02/2009 | CN101518334A Spleen-strengthening, kidney-tonifying and blood sugar reducing cake |
| 09/02/2009 | CN101518298A Production method of emulsified solution containing majoram oil for livestock and fowl drinking water |
| 09/02/2009 | CN100534991C Heterocyclic inhibitors of ERK 2 and uses thereof |
| 09/02/2009 | CN100534988C 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof |
| 09/02/2009 | CN100534981C 2-propylidene-19-nor-vitamin d compounds |
| 09/02/2009 | CN100534523C Health food having delaying senility and beautifying function and preparation method thereof |
| 09/02/2009 | CN100534506C Chinese medicinal mixture for treating viral hepatitis |
| 09/02/2009 | CN100534438C Difructose anhydride-containing composition and use thereof |
| 09/02/2009 | CN100534436C Polynucleotide therapy |
| 09/01/2009 | US7582734 natural ligand for the orphan G-Protein Coupled Receptor (GPCR) ChemerinR and uses thereof in diagnosis and immuno therapy of a disease; monoclonal antibody; chemiattractant proteins; useful for the diagnosis and treatment of a disease or disorder related to the dysregulation of GPCR signaling |
| 09/01/2009 | US7582660 2-thio-substituted imidazole derivatives and their use in pharmaceutics |
| 09/01/2009 | US7582657 Vanilloid receptor ligands and their use in treatments |
| 09/01/2009 | US7582654 Antiarrhythmia agents, treating gastrointensinal disorder, gastroesophageal reflux, chronic obstructive pulmonary disease, diabetes;N-cotnaining heterocyclic compound with carbamate or amide groups and indazole ring |
| 09/01/2009 | US7582644 Pyrimidyl sulphone amide derivatives as chemokine receptor modulators |
| 09/01/2009 | US7582619 Administering pyrimidine nucleotide precursor where respiratory chain dysfunction is caused by mutation, deletion, or rearrangement of mitochondrial DNA, cytotoxic cancer chemotherapy agents, aging |
| 09/01/2009 | US7582603 Treatment of gastrointestinal inflammation by administering a peptide antagonist of tight junction opening that binds to the zonula occludens receptor, yet does not physiologically modulate the opening of mammalian tight junctions; celiac disease, inflammatory bowel disease |
| 09/01/2009 | US7582313 Methods of organ regeneration using Hox 11-expressing pluripotent cells |
| 09/01/2009 | US7582305 Method for suppressing diarrhea in pigs, wherein a composition comprising killed bacteria of Enterococcus faecalis EC-12 (FERM ABP-10284) as an active ingredient is orally administered to pigs; efficiency |
| 09/01/2009 | CA2520043C Novel galactooligosaccharide composition and the preparation thereof |
| 09/01/2009 | CA2467378C Cereal beta glucan compositions, methods of preparation and uses thereof |
| 09/01/2009 | CA2432428C Quinazoline derivatives, pharmaceutical compositions containing these compounds, their use and processes for preparing them |
| 09/01/2009 | CA2385867C Sustained release form comprising alpha-lipoic acid or derivatives thereof |
| 09/01/2009 | CA2292325C Symbiotic functional food |
| 09/01/2009 | CA2210812C T-cell affecting peptides |
| 08/27/2009 | WO2009105629A2 Methods for the treatment and prevention of necrotizing enterocolitis |
| 08/27/2009 | WO2009105328A2 Inorganic sorbent copolymer |
| 08/27/2009 | WO2009105234A2 Methods and compositions for the treatment of disorders associated with defects of the cystic fibrosis transmembrane conductance regulator gene or protein |
| 08/27/2009 | WO2009104729A1 Amide derivative and pharmaceutical composition containing the same |
| 08/27/2009 | WO2009104248A1 Adrenomedullin production enhancer |
| 08/27/2009 | WO2009103884A2 Composition for human and/or animal nutrition, uses thereof and yeasts |
| 08/27/2009 | WO2009103788A1 Compositions comprising phytoestrogens selective for estrogen beta receptor and dietary fibres |
| 08/27/2009 | WO2009083738A3 Rna delivery vehicles |
| 08/27/2009 | WO2006106994A8 Drug for periodontal disease comprising component extracted from aesculus hippocastanum l. |
| 08/27/2009 | US20090215995 isolated nucleic acids encoding B7-related polypeptides, including BSL3, which modulate cells that are important for immune and inflammatory responses, such as T-cells |
| 08/27/2009 | US20090215890 Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers |
| 08/27/2009 | US20090215847 Tricyclic Angiotensin II Agonists |
| 08/27/2009 | US20090215831 Inhibitors of the gastric h+, k+-atpase with enhanced therapeutic properties |
| 08/27/2009 | US20090215830 Multiple ppi dosage form |
| 08/27/2009 | US20090215809 crystalline calcium (3S)-{[(1R)-isobutanoyloxyethoxy]carbonylaminomethyl}-5-methyl-hexanoate hydrate; sustained release oral dosage formualtion with opioid agonist, selective serotonin re-uptake inhibitor and noradrenaline re-uptake inhibitor; an inflammatory disease, neuropathic pain, anxiety, psychosis |
| 08/27/2009 | US20090215771 Jun N-terminal kinase inhibitors; 1H-pyrrolo[2,3-b]pyridines 3-substituted with a C 5-7 carbocycle and 5-substituted by a 5-member heterocycle; 3-(p-(dimethylamino)phenyl)-5-(2-thiazolyl-1H-pyrrolo[2,3-b]pyridine; neurodegenerative disorders related to apoptosis and/or inflammation |
| 08/27/2009 | US20090215758 Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs |
| 08/27/2009 | US20090215736 inhibitors of apoptosis and IL-1 beta secretion; mediate cell apoptosis and inflammation; good cell penetration and pharmacokinetic properties; [3S/R(2S)]3-[2-(Carbazol-9-yl-2-oxo-ethyl)-pentanoylamino]-5-fluoro-4-oxo-pentanoic acid |